Axogen, Inc. (LON:0HKD)
30.01
+0.08 (0.26%)
At close: Dec 12, 2025
Axogen Employees
As of December 31, 2024, Axogen had 452 total employees, including 451 full-time and 1 part-time employees. The number of employees increased by 24 or 5.61% compared to the previous year.
Employees
452
Change (1Y)
24
Growth (1Y)
5.61%
Revenue / Employee
353.39K GBP
Profits / Employee
-3.45K GBP
Market Cap
1.05B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 452 | 24 | 5.61% |
| Dec 31, 2023 | 428 | 32 | 8.08% |
| Dec 31, 2022 | 396 | -55 | -12.20% |
| Dec 31, 2021 | 451 | 83 | 22.55% |
| Dec 31, 2020 | 368 | -26 | -6.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Axogen News
- 12 hours ago - Insider Sell: Marc Began Sells Shares of Axogen Inc (AXGN) - GuruFocus
- 2 days ago - Insider Sell: Paul Thomas Sells 21,399 Shares of Axogen Inc (AXGN) - GuruFocus
- 7 days ago - AXGN: Canaccord Genuity Raises Price Target to $37, Maintains Buy Rating | AXGN Stock News - GuruFocus
- 8 days ago - Jefferies Raises Axogen (AXGN) Price Target to $36, Maintains Buy Rating | AXGN Stock News - GuruFocus
- 8 days ago - Axogen Smashes 52-Week High On FDA Nod For Breakthrough Nerve Repair Treatment - Benzinga
- 8 days ago - FDA Approves Axogen's (AXGN) Avance for Nerve Repair - GuruFocus
- 9 days ago - Axogen gets FDA OK for Avance’s biologics license application - Seeking Alpha
- 9 days ago - FDA Approves Axogen's AVANCE Nerve Allograft For Peripheral Nerve Repair - Nasdaq